The Role of Biochemical Markers in the Prediction of Preeclampsia
Renad Marwan Alghifari, Nuwayir Ibrahim Alhusayni, Zahrah Fuad Alyamani, Aliaa Sabban, Yousef Almoghrabi, Khalid Hussein Bakheit
International Journal of Biochemistry Research & Review · pp. 39–47 · Published 2 Nov 2023
10.9734/ijbcrr/2023/v32i8833Abstract
Preeclampsia is disorder unique to human pregnancy, defined by the international society of the study of hypertension in pregnancy (ISSHP). It causes significant maternal and neonatal morbidity and mortality. Measures to predict preeclampsia are very valuable for fetal and maternal health. This review aims to focus on the role of biochemical markers in the prediction of preeclampsia, which may help early detection and improve outcome of pregnancy. It was found that the efficiency and accuracy heavily depended on the timeline of pregnancy, moreover, some biochemical markers are considered more accurate when accompanied with ultrasound scan. Many of these biochemical markers are measured in the first trimester, and the normal ranges in normal pregnant women and preeclamptic women differ majorly, where some are notably increased during the first trimester, opposed to others that are decreased. The results of this review showed the markers that are important in picking up women at risk of developing preeclampsia early from the first trimester.
References (57)
- 1 Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia [DOI]
- 2 Circulating Angiogenic Factors and the Risk of Preeclampsia [DOI]
- 3 The American Journal of Obstetrics and Gynecology 1920–1945 [DOI]
- 4 Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia [DOI]
- 5 Oxidative Stress in Preeclampsia and Placental Diseases [DOI]
- 6 The two-stage placental model of preeclampsia: An update [DOI]
- 7 Biochemical Markers of Bone Metabolism: An Overview [DOI]
- 8 Reproductive Biology and Endocrinology
- 9 IFPA Senior Award Lecture: Making sense of pre-eclampsia – Two placental causes of preeclampsia? [DOI]
- 10 Longitudinal serum concentrations of placental growth factor: Evidence for abnormal placental angiogenesis in pathologic pregnancies [DOI]
- 11 Oxidative stress: Normal pregnancy versus preeclampsia [DOI]
- 12 Redefining Preeclampsia Using Placenta-Derived Biomarkers [DOI]
- 13 Elevated Blood Pressure in Pregnancy and Subsequent Chronic Disease Risk [DOI]
- 14 The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals [DOI]
- 15 Potential markers of preeclampsia – a review [DOI]
- 16 First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction [DOI]
- 17 Proteinuria during pregnancy: definition, pathophysiology, methodology, and clinical significance [DOI]
- 18 Oxidative stress in preeclampsia and the role of free fetal hemoglobin [DOI]
- 19 Effect of early-onset preeclampsia on cardiovascular risk in the fifth decade of life [DOI]
- 20 4-Hydroxyglutamate is a novel predictor of pre-eclampsia [DOI]
- 21 Blood Pressure Patterns in Normal Pregnancy, Gestational Hypertension, and Preeclampsia [DOI]
- 22 First‐trimester ADAM12 and PAPP‐A as markers for intrauterine fetal growth restriction through their roles in the insulin‐like growth factor system [DOI]
- 23 First-trimester maternal serum PP13 in the risk assessment for preeclampsia [DOI]
- 24 Reduction of the Disintegrin and Metalloprotease ADAM12 in Preeclampsia [DOI]
- 25 ADAM12s in maternal serum as a potential marker of pre‐eclampsia [DOI]
- 26 Serum visfatin levels in late pregnancy and pre‐eclampsia [DOI]
- 27 Relationships of Risk Factors for Pre-Eclampsia with Patterns of Occurrence of Isolated Gestational Proteinuria during Normal Term Pregnancy [DOI]
- 28 Pregnancy-Associated Plasma Protein A (PAPP-A) and Preeclampsia [DOI]
- 29 Preeclampsia: increased expression of soluble ADAM 12 [DOI]
- 30 Total Versus Free Placental Growth Factor Levels in the Pathogenesis of Preeclampsia [DOI]
- 31 Investigating Maternal Brain Alterations in Preeclampsia: the Need for a Multidisciplinary Effort [DOI]
- 32 Proteinuria in preeclampsia: is it important? [DOI]
- 33 PAPP‐A2 and Inhibin A as Novel Predictors for Pregnancy Complications in Women With Suspected or Confirmed Preeclampsia [DOI]
- 34 MiR-149-5p: An Important miRNA Regulated by Competing Endogenous RNAs in Diverse Human Cancers [DOI]
- 35 Down-regulated miR-149-5p contributes to preeclampsia via modulating endoglin expression [DOI]
- 36 Serum Inhibin-A and PAPP-A2 in the prediction of pre-eclampsia during the first and second trimesters in high-risk women [DOI]
- 37 The hemoglobin degradation pathway in patients with preeclampsia – Fetal hemoglobin, heme, heme oxygenase-1 and hemopexin – Potential diagnostic biomarkers? [DOI]
- 38 Urinary protein-to-creatinine ratio in pregnant women after dipstick testing: prospective observational study [DOI]
- 39 Potential Protein Biomarkers for Preeclampsia [DOI]
- 40 Circulating soluble fms-like tyrosine kinase-1 is placentally derived in normal pregnancy: First in vivo evidence [DOI]
- 41 Adipokine Serum visfatin level in pregnancy induced hypertension and uncomplicated pregnancy [DOI]
- 42 Predictive value of 4-Hydroxyglutamate and miR-149-5p on eclampsia [DOI]
- 43 Diagnostic value of doppler ultrasound indices of maternal renal interlobar vasculature in the prediction of preeclampsia [DOI]
- 44 Serum beta human chorionic gonadotropin levels and preeclampsia [DOI]
- 45 Inhibin A levels and severity of preeclampsia [DOI]
- 46 Placenta Weight in Preeclampsia [DOI]
- 47 International Journal of Molecular Sciences [DOI]
- 48 Experimental and Therapeutic Medicine [DOI]
- 49 Archives of Gynecology and Obstetrics [DOI]
- 50 Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia [DOI]
- 51 Clinical Utility of sFlt-1 and PlGF in Screening, Prediction, Diagnosis and Monitoring of Pre-eclampsia and Fetal Growth Restriction [DOI]
- 52 Predictive performance of first trimester serum galectin‑13/PP‑13 in preeclampsia screening: A systematic review and meta‑analysis [DOI]
- 53 The feasibility of soluble Fms-Like Tyrosine kinase-1 (sFLT-1) and Placental Growth Factor (PlGF) ratio biomarker in predicting preeclampsia and adverse pregnancy outcomes among medium to high risk mothers in Kuala Lumpur, Malaysia [DOI]
- 54 Preeclampsia: Still a Disease of Theories [DOI]
- 55 100 Years of Human Chorionic Gonadotropin [DOI]
- 56 Prevalence of pregnancy induced hypertension in our hospital [DOI]
- 57 Acta Obstetricia et Gynecologica Scandinavica [DOI]
Cited by 4
Bhaskar Debbarma, Sathi Debbarma, Donga Durga Veera Hanuman, M Usha Rani, Sravathi Vemula, Koppula Anusha, B.D.P. Kala Kumar, B. Anil Kumar, Bobbili Rajender · Journal of Advances in Biology & Biotechnology · 2024
幸霖 李 · Advances in Clinical Medicine · 2024
Showing 2 of 4 known citations — external sources report more than can currently be individually listed.
Related research
- Perceived Stress and Anxiety in Women during Labour: A Case of Tamale West Hospital, Tamale, Ghana — shares topic coverage
- Mycoplasma genitalium in Infertile and Pregnant Women in Lagos, Nigeria — shares topic coverage
- Asymptomatic Bacteriuria among Pregnant Women at University Hospital in Uyo, Nigeria: Prevalence, Risk Factors and Characteristics — shares topic coverage
- Advancing Exclusive Breastfeeding among HIV-Positive Mothers in Low Resource Settings — shares topic coverage
- Anaemia in Pregnancy at Booking: Prevalence and Risk Factors among Antenatal Attendees in a Southern Nigeria General Hospital — shares topic coverage
Article metrics
Real usage data collected on this platform.
68
Page views
0
PDF downloads
15
Outbound clicks
4
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.